ClinicalTrials.Veeva

Menu

Functional Impairment in Albinism (PLAIB)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Enrolling

Conditions

Albinism, Ocular

Treatments

Other: questionnaire

Study type

Observational

Funder types

NETWORK

Identifiers

NCT06345976
RLX_2023_10

Details and patient eligibility

About

Albinism is a genetic and hereditary anomaly that affects pigmentation. This pathology is characterized by a deficit in melanin production. In humans, the clinical diagnosis of albinism is based on a number of factors, including :

  • In the integumentary region: fair skin tone, with white hair, eyelashes and eyebrows.
  • Ophthalmological: reduced visual acuity, photophobia, nystagmus, transilluminated blue irises, hypopigmentation of the retina at the back of the eye with fovea plana.

As treatment options begin to emerge for certain albinism-induced anomalies (including, for example, the depigmentation that causes photophobia), it is desirable to understand what these patients' complaints are, and to gather their views on the emergence of treatments targeting just one of their complaints, namely glare.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients with albinism
  • Patients > 18 years of age
  • Non-opposition to study participation

Exclusion criteria

No diagnosis according to Kruijt et al. criteria Impossibility (visual, technological) of completing questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Amélie Yavchitz

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems